journal cover

Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo

AIDS

Jan 3, 2020

Mounerou SalouMartine Peeters

Abstract

Evaluate the potential effectiveness of the implementation of DTG-based regimens in patients on failing current ART given the high levels of NRTI resistance in Togo. Patients on ART attending health facilities for routine follow-up visits and for whom HIV viral load (VL) test was perfor...read more

Mentioned in this Paper

Peptide Hydrolases
Dolutegravir
Blinded
TERT gene
Second Line Treatment
Hoover Technique
Non-nucleoside Reverse Transcriptase Inhibitor
First-Line Therapy
Virus
Integrase Inhibitors
3
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

HIV: Cell & Gene Therapy

This feed focuses on emerging cell and gene therapies, such as HIV vaccines, for treating patients living with HIV/AIDS. Discover the latest research here.

Oxygenation & Hydroxylation

Oxygenation is a chemical production that introduces oxygen atom into an organic compound. Hydroxylation is a chemical process that introduces a hydroxyl group (-OH) into an organic compound. In biochemistry, hydroxylation reactions are often facilitated by enzymes called hydroxylases. Cytochrome P450 (CYP) enzymes are expressed mainly in the liver and are active in mono-oxygenation and hydroxylation of various xenobiotics, including drugs and alcohols, as well as that of endogenous compounds such as steroids, bile acids, prostaglandins, leukotrienes and biogenic amines. Here is the latest research.

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

© 2020 Meta ULC. All rights reserved

Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo

AIDS

Jan 3, 2020

Mounerou SalouMartine Peeters

PMID: 31895149

DOI: 10.1097/qad.0000000000002470

Abstract

Evaluate the potential effectiveness of the implementation of DTG-based regimens in patients on failing current ART given the high levels of NRTI resistance in Togo. Patients on ART attending health facilities for routine follow-up visits and for whom HIV viral load (VL) test was perfor...read more

Mentioned in this Paper

Peptide Hydrolases
Dolutegravir
Blinded
TERT gene
Second Line Treatment
Hoover Technique
Non-nucleoside Reverse Transcriptase Inhibitor
First-Line Therapy
Virus
Integrase Inhibitors
3

Similar Papers Found In These Feeds

HIV: Cell & Gene Therapy

This feed focuses on emerging cell and gene therapies, such as HIV vaccines, for treating patients living with HIV/AIDS. Discover the latest research here.

Related Papers

AIDS Research and Human Retroviruses

Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda

AIDS Research and Human RetrovirusesMarch 27, 2012
Steven J ReynoldsSusan H Eshleman
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/challenges-of-scale-up-to-dolutegravir-based/31895149